Analyst Price Targets — DBD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 13, 2026 2:18 pm | Matt Summerville | D.A. Davidson | $100.00 | $81.19 | TheFly | Diebold price target raised to $100 from $80 at DA Davidson |
| February 13, 2026 1:59 pm | — | Wedbush | $100.00 | $79.83 | TheFly | Diebold price target raised to $100 from $80 at Wedbush |
| August 7, 2025 1:08 pm | Antoine Legault | Wedbush | $70.00 | $60.00 | TheFly | Diebold price target raised to $70 from $60 at Wedbush |
| May 3, 2024 7:07 am | Matt Bryson | Wedbush | $50.00 | $38.01 | StreetInsider | Wedbush Upgrades Diebold Nixdorf (DBD) to Outperform |
| November 10, 2023 6:34 am | Matthew Summerville | D.A. Davidson | $29.00 | $21.21 | StreetInsider | DA Davidson Upgrades Diebold Nixdorf (DBD) to Buy, 'Too Cheap to Ignore' |
| July 8, 2022 7:08 am | Matt Bryson | Wedbush | $5.00 | $3.04 | StreetInsider | Wedbush Upgrades Diebold (DBD) to Outperform |
| April 30, 2022 11:52 am | Matt Summerville | D.A. Davidson | $7.00 | $4.10 | Pulse 2.0 | Diebold Nixdorf (DBD) Stock: $7 Price Target And Buy Rating |
Latest News for DBD
Diebold Nixdorf, Incorporated (DBD) closed at $84.36 in the latest trading session, marking a -1.41% move from the prior day.
In the closing of the recent trading day, Diebold Nixdorf, Incorporated (DBD) stood at $84.99, denoting a +1.8% move from the preceding trading day.
Recently, Zacks.com users have been paying close attention to Diebold Nixdorf, Incorporated (DBD). This makes it worthwhile to examine what the stock has in store.
NORTH CANTON, Ohio, July 8, 2026 /PRNewswire/ -- Diebold Nixdorf (NYSE: DBD), a world leader in transforming the way people bank and shop, will release second quarter 2026 financial results on Wednesday, July 29, before trading begins on the New York Stock Exchange. Octavio Marquez, president and chief executive officer, and Tom Timko, executive vice president and chief financial officer, will discuss the results…
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for DBD.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.